Stay updated on MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial
Sign up to get notified when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.

Latest updates to the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe revision history shows a new entry for v3.3.2, replacing the previous v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedThe Revision label changed from v3.2.0 to v3.3.1 on the page; this update does not affect study data, content, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the government funding lapse notice that warned data may not be up to date; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check34 days agoChange DetectedThe new version shows updated study and recruitment status and expands sections for Study Design and Outcome Measures, including a QC status.SummaryDifference0.1%

- Check63 days agoChange DetectedSummary of changes: added a government funding notice with current operating status and links; updated version to v3.2.0; removed the old version label v3.1.0.SummaryDifference12%

- Check70 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.